Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$104.74 USD

104.74
7,349,697

+0.07 (0.07%)

Updated May 10, 2024 04:00 PM ET

After-Market: $104.80 +0.06 (0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

IDEXX Laboratories (IDXX) Set to Join the S&P 500 Index

IDEXX Laboratories, Inc. (IDXX) is scheduled to join the coveted S&P 500 benchmark, after the market closes on Jan 4.

    Abbott Labs to Close St. Jude Acquisition Later this Week

    Abbott Laboratories (ABT) announced to close the acquisition of St. Jude Medical, Inc., (STJ) on Jan 4, 2017.

      AbbVie's Humira and Imbruvica Drive Performance in 2016

      AbbVie Inc.'s (ABBV) share price is up 5.9% so far this year.

        Abbott to Sell 2 Medical Device Businesses for St. Jude Buyout

        Abbott Laboratories (ABT) has agreed to divest two medical device businesses in order to settle Federal Trade Commission (FTC) charges in relation to its proposed acquisition of St. Jude Medical (STJ).

          Mylan (MYL) Stock Falls on Restructuring Plans, Layoffs

          Mylan (MYL) has revealed restructuring programs in certain locations in an attempt to streamline its operations globally as it focuses on integrating acquisitions.

            Mark Vickery headshot

            Q3 Earnings Continue, Housing and Permits Mixed

            Housing starts fell 9% but building permits rose 6.3%. We also see earnings results from Morgan Stanley, U.S. Bancorp, Abbott Labs, Halliburton and Seagate.

              Mark Vickery headshot

              Q2 Earnings Season Coming Up Roses

              Morgan Stanley, Abbott Labs and Halliburton all beat earnings expectations before the opening bell today.

                Kevin Cook headshot

                Bear of the Day: AbbVie (ABBV)

                Estimates were already sliding before the Feds took up the patent fight by "hopeful rival" Coherus

                  Sheraz Mian headshot

                  Parade of Mixed Earnings

                  Stocks have made solid gains in recent sessions, pushing the S&P 500 index above the 2100 level.

                    Eric Dutram headshot

                    Bear of the Day: Abbott Labs (ABT)

                    This stock could infect your portfolio thanks to its sluggish outlook and crumbling earnings estimates.